marketcaparena
Search

    LNTH

    Lantheus Holdings, Inc.

    Company overview

    Market capitalization
    $6.51B
    Employees
    1,193
    Latest publication
    2026-09-29
    About Lantheus Holdings, Inc.

    Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. It also provides Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; PYLARIFY AI, an medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer; and flurpiridaz used to assess blood flow to the heart. In addition, it develops PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy to patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent for Tau tangles in Alzheimer's disease; LNTH-2401, a novel radiodiagnostic targeting the gastrin-releasing peptide receptor; LNTH-2402; LNTH-2403; LNTH-2404; LNTH-250; LNTH-2515; and LNTH-1363S, an fibroblast activation protein, alpha, copper-64 labeled PET imaging agent. It has collaboration agreements with GE Healthcare; Curium Pharma; POINT; Regeneron; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue388,180,000USD377,333,000USD406,786,000USD384,014,000USD378,045,000USD372,764,000USD391,110,000USD378,734,000USD
    Cost Of Revenue146,325,000USD146,411,000USD165,911,000USD161,648,000USD137,034,000USD135,064,000USD142,565,000USD136,608,000USD
    Gross Profit241,855,000USD230,922,000USD240,875,000USD222,366,000USD241,011,000USD237,700,000USD248,545,000USD242,126,000USD
    Research Development38,202,000USD39,379,000USD47,480,000USD48,025,000USD45,489,000USD36,314,000USD35,325,000USD24,148,000USD
    Selling General Administrative20,633,000USD57,533,000USD69,892,000USD81,898,000USD66,515,000USD56,816,000USD57,869,000USD40,516,000USD
    Selling And Marketing Expenses82,805,000USD52,684,000USD46,319,000USD48,828,000USD41,041,000USD42,503,000USD—43,719,000USD
    General And Administrative Expenses20,633,000USD———————
    Total Operating Expenses141,640,000USD149,596,000USD163,691,000USD178,751,000USD153,045,000USD135,633,000USD134,673,000USD108,383,000USD
    Operating Income100,215,000USD81,326,000USD77,184,000USD43,615,000USD87,966,000USD102,067,000USD113,872,000USD133,743,000USD
    Total Other Income Expense Net-6,390,000USD75,079,000USD-6,819,000USD-1,234,000USD16,551,000USD-5,538,000USD-114,655,000USD42,375,000USD
    Interest Expense4,915,000USD4,864,000USD5,078,000USD4,950,000USD4,917,000USD4,804,000USD5,045,000USD4,903,000USD
    Income Before Tax93,825,000USD156,405,000USD70,365,000USD42,381,000USD104,517,000USD96,529,000USD-783,000USD176,118,000USD
    Income Tax Expense18,796,000USD37,988,000USD16,277,000USD14,610,000USD25,762,000USD23,584,000USD11,007,000USD45,025,000USD
    Net Income75,029,000USD118,417,000USD54,088,000USD27,771,000USD78,755,000USD72,945,000USD-11,790,000USD131,093,000USD
    Net Income Applicable To Common Shares75,029,000USD———————
    Interest Income—4,969,000USD3,073,000USD3,623,000USD7,213,000USD9,482,000USD9,565,000USD9,801,000USD
    Net Interest Income—105,000USD-2,005,000USD-1,327,000USD2,296,000USD4,678,000USD4,520,000USD4,898,000USD
    Tax Provision—37,988,000USD16,277,000USD14,610,000USD25,762,000USD23,584,000USD11,007,000USD45,025,000USD
    Net Income From Continuing Ops—118,417,000USD54,088,000USD27,771,000USD78,755,000USD72,945,000USD-11,790,000USD131,093,000USD
    Ebit—161,269,000USD75,443,000USD47,331,000USD109,434,000USD101,333,000USD4,262,000USD181,021,000USD
    Ebitda—183,952,000USD98,261,000USD67,739,000USD122,665,000USD114,959,000USD21,547,000USD198,096,000USD
    Depreciation And Amortization—22,683,000USD22,818,000USD20,408,000USD13,231,000USD13,626,000USD17,285,000USD17,075,000USD
    Reconciled Depreciation—22,683,000USD22,833,000USD20,408,000USD13,231,000USD13,626,000USD17,285,000USD17,075,000USD
    Unclassified Operating Expenses——————41,479,000USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USD
    Total Revenue1,541,609,000USD1,533,910,000USD1,296,429,000USD935,061,000USD347,337,000USD343,374,000USD331,378,000USD301,853,000USD
    Cost Of Revenue599,657,000USD545,619,000USD586,886,000USD353,358,000USD172,526,000USD168,489,000USD169,243,000USD164,073,000USD
    Gross Profit941,952,000USD988,291,000USD709,543,000USD581,703,000USD174,811,000USD174,885,000USD162,135,000USD137,780,000USD
    Research Development177,308,000USD168,098,000USD77,707,000USD311,681,000USD20,018,000USD17,071,000USD18,125,000USD12,203,000USD
    Selling General Administrative275,121,000USD193,689,000USD125,458,000USD133,584,000USD61,244,000USD50,167,000USD49,842,000USD38,832,000USD
    Selling And Marketing Expenses178,691,000USD—141,736,000USD100,243,000USD41,888,000USD43,159,000USD42,315,000USD36,542,000USD
    Total Operating Expenses631,120,000USD531,312,000USD344,901,000USD545,508,000USD123,150,000USD110,397,000USD110,282,000USD87,577,000USD
    Operating Income310,832,000USD456,979,000USD364,642,000USD36,195,000USD51,661,000USD64,488,000USD51,853,000USD56,588,000USD
    Interest Income23,391,000USD36,838,000USD19,638,000USD2,613,000USD686,000USD17,962,000USD18,157,000USD27,471,000USD
    Interest Expense19,749,000USD19,669,000USD20,019,000USD7,185,000USD13,617,000USD17,405,000USD18,410,000USD26,618,000USD
    Net Interest Income3,642,000USD17,169,000USD-381,000USD-4,572,000USD-12,931,000USD-17,405,000USD-18,410,000USD-26,618,000USD
    Income Before Tax313,792,000USD430,977,000USD410,943,000USD26,719,000USD28,627,000USD49,548,000USD39,639,000USD28,294,000USD
    Income Tax Expense80,233,000USD118,535,000USD84,282,000USD-1,348,000USD-3,040,000USD9,030,000USD-83,746,000USD1,532,000USD
    Tax Provision80,233,000USD118,535,000USD84,282,000USD-1,348,000USD-3,040,000USD9,030,000USD-83,746,000USD1,532,000USD
    Net Income233,559,000USD312,442,000USD326,661,000USD28,067,000USD31,667,000USD40,518,000USD123,385,000USD26,762,000USD
    Net Income From Continuing Ops233,559,000USD312,442,000USD326,661,000USD28,067,000USD31,667,000USD40,518,000USD123,385,000USD26,762,000USD
    Ebit333,541,000USD450,646,000USD430,962,000USD33,904,000USD42,244,000USD66,953,000USD58,049,000USD54,912,000USD
    Ebitda403,639,000USD515,270,000USD491,005,000USD81,833,000USD55,623,000USD80,813,000USD77,191,000USD73,175,000USD
    Depreciation And Amortization70,098,000USD64,624,000USD60,043,000USD47,929,000USD13,379,000USD13,860,000USD19,142,000USD18,263,000USD
    Reconciled Depreciation70,098,000USD64,624,000USD60,043,000USD47,929,000USD13,379,000USD13,929,000USD19,231,000USD—
    Total Other Income Expense Net2,960,000USD-26,002,000USD46,301,000USD-9,476,000USD-23,034,000USD-14,940,000USD-12,214,000USD-28,294,000USD
    Unclassified Operating Expenses—169,525,000USD——————
    Non Operating Income Net Other———-2,291,000USD-9,417,000USD2,465,000USD6,196,000USD-1,676,000USD
    Net Income Applicable To Common Shares———28,067,000USD31,667,000USD40,518,000USD123,385,000USD26,762,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets2,414,662,000USD2,346,587,000USD2,227,399,000USD2,276,400,000USD2,116,077,000USD2,055,224,000USD1,980,340,000USD2,049,630,000USD
    Cash And Equivalents593,298,000USD———————
    Total Current Assets1,027,059,000USD942,288,000USD899,964,000USD925,091,000USD1,201,816,000USD1,423,780,000USD1,326,633,000USD1,295,714,000USD
    Other Current Assets22,154,000USD26,701,000USD117,529,000USD97,792,000USD107,508,000USD67,372,000USD24,536,000USD29,157,000USD
    Other Non Current Assets59,719,000USD———————
    Total Liabilities1,102,884,000USD———————
    Total Current Liabilities335,677,000USD333,166,000USD333,419,000USD346,838,000USD280,132,000USD248,002,000USD240,526,000USD784,079,000USD
    Other Non Current Liabilities91,534,000USD———————
    Total Stockholder Equity1,311,778,000USD1,212,288,000USD1,089,797,000USD1,119,206,000USD1,166,783,000USD1,164,194,000USD1,088,011,000USD1,179,708,000USD
    Total Equity Including Noncontrolling Interest1,311,778,000USD———————
    Short Long Term Debt697,000USD803,000USD738,000USD871,000USD796,000USD747,000USD974,000USD564,713,000USD
    Long Term Debt570,354,000USD569,604,000USD568,678,000USD567,937,000USD566,847,000USD566,098,000USD565,279,000USD613,000USD
    Net Receivables352,887,000USD355,666,000USD358,640,000USD383,253,000USD336,579,000USD348,749,000USD321,258,000USD329,336,000USD
    Inventory57,551,000USD61,339,000USD64,674,000USD62,040,000USD62,157,000USD69,126,000USD68,025,000USD70,835,000USD
    Property Plant Equipment Net153,270,000USD157,563,000USD163,686,000USD164,072,000USD157,726,000USD180,783,000USD212,881,000USD208,858,000USD
    Goodwill239,050,000USD———————
    Intangible Assets689,335,000USD706,058,000USD722,779,000USD739,264,000USD359,946,000USD153,745,000USD161,761,000USD173,606,000USD
    Accounts Payable48,109,000USD45,875,000USD42,906,000USD66,296,000USD40,891,000USD44,874,000USD34,560,000USD44,914,000USD
    Common Stock725,000USD723,000USD718,000USD718,000USD717,000USD716,000USD709,000USD709,000USD
    Retained Earnings872,950,000USD797,921,000USD679,504,000USD625,416,000USD597,645,000USD518,890,000USD445,945,000USD457,735,000USD
    Accumulated Other Comprehensive Income-2,166,000USD-1,867,000USD-1,307,000USD-1,665,000USD-1,482,000USD-1,758,000USD-1,615,000USD-1,166,000USD
    Total Liab—1,134,299,000USD1,137,602,000USD1,157,194,000USD949,294,000USD891,030,000USD892,329,000USD869,922,000USD
    Other Current Liab—286,488,000USD285,971,000USD279,671,000USD236,980,000USD187,083,000USD204,992,000USD174,452,000USD
    Capital Stock—723,000USD718,000USD718,000USD717,000USD716,000USD709,000USD709,000USD
    Good Will—239,399,000USD239,517,000USD240,328,000USD176,869,000USD61,189,000USD61,189,000USD61,189,000USD
    Cash—498,582,000USD359,121,000USD382,006,000USD695,572,000USD938,533,000USD912,814,000USD866,386,000USD
    Cash And Short Term Investments—498,582,000USD359,121,000USD382,006,000USD695,572,000USD938,533,000USD912,814,000USD866,386,000USD
    Net Debt—127,170,000USD314,131,000USD237,431,000USD-80,078,000USD-324,130,000USD-293,376,000USD-247,145,000USD
    Short Term Debt—803,000USD4,542,000USD871,000USD796,000USD747,000USD974,000USD564,713,000USD
    Short Long Term Debt Total—625,752,000USD673,252,000USD619,437,000USD615,494,000USD614,403,000USD619,438,000USD619,241,000USD
    Long Term Investments—58,312,000USD42,213,000USD46,474,000USD45,068,000USD30,375,000USD39,489,000USD158,791,000USD
    Property Plant Equipment Gross—239,271,000USD267,451,000USD234,197,000USD223,182,000USD294,739,000USD321,643,000USD286,679,000USD
    Common Stock Shares Outstanding—65,772,000shares66,315,000shares67,663,000shares70,312,000shares71,461,000shares69,217,000shares73,065,000shares
    Non Current Assets Total—1,404,299,000USD1,327,435,000USD1,351,309,000USD914,261,000USD631,444,000USD653,707,000USD753,916,000USD
    Non Current Liabilities Total—801,133,000USD804,183,000USD810,356,000USD669,162,000USD643,028,000USD651,803,000USD85,843,000USD
    Non Current Liabilities Other—122,537,000USD131,105,000USD136,575,000USD54,328,000USD10,632,000USD9,995,000USD8,078,000USD
    Non Currrent Assets Other—153,845,000USD50,044,000USD52,023,000USD36,390,000USD36,467,000USD8,154,000USD6,831,000USD
    Net Working Capital—609,122,000USD566,545,000USD578,253,000USD921,684,000USD1,175,778,000USD1,086,107,000USD511,635,000USD
    Unclassified Non Current Assets—89,122,000USD109,196,000USD109,148,000USD138,262,000USD168,885,000USD170,233,000USD144,641,000USD
    Unclassified Non Current Liabilities—108,992,000USD104,400,000USD105,844,000USD47,987,000USD66,298,000USD76,529,000USD77,152,000USD
    Unclassified Equity—414,788,000USD410,164,000USD494,019,000USD569,186,000USD645,630,000USD642,263,000USD721,721,000USD
    Unclassified Current Liabilities—————14,551,000USD—-564,713,000USD
    Short Term Investments———————-1,663,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets2,227,399,000USD1,980,340,000USD1,651,149,000USD1,321,258,000USD863,784,000USD869,821,000USD405,919,000USD439,831,000USD
    Intangible Assets722,779,000USD161,761,000USD151,985,000USD315,285,000USD348,510,000USD376,012,000USD7,336,000USD9,133,000USD
    Other Current Assets117,529,000USD24,536,000USD23,842,000USD13,092,000USD12,818,000USD14,867,000USD7,283,000USD5,242,000USD
    Total Liab1,137,602,000USD892,329,000USD835,257,000USD874,111,000USD399,345,000USD355,616,000USD291,318,000USD368,829,000USD
    Total Stockholder Equity1,089,797,000USD1,088,011,000USD815,892,000USD447,147,000USD464,439,000USD514,205,000USD114,601,000USD71,002,000USD
    Other Current Liab289,775,000USD204,992,000USD145,338,000USD226,784,000USD58,068,000USD43,519,000USD37,217,000USD32,050,000USD
    Common Stock718,000USD709,000USD699,000USD689,000USD677,000USD669,000USD393,000USD385,000USD
    Capital Stock718,000USD709,000USD699,000USD689,000USD677,000USD669,000USD393,000USD385,000USD
    Retained Earnings679,504,000USD445,945,000USD133,503,000USD-193,158,000USD-221,225,000USD-149,946,000USD-136,473,000USD-168,140,000USD
    Good Will239,517,000USD61,189,000USD61,189,000USD61,189,000USD61,189,000USD58,632,000USD15,714,000USD15,714,000USD
    Cash359,121,000USD912,814,000USD713,656,000USD415,652,000USD98,508,000USD79,612,000USD92,919,000USD113,401,000USD
    Cash And Short Term Investments359,121,000USD912,814,000USD713,656,000USD415,652,000USD98,508,000USD79,612,000USD92,919,000USD113,401,000USD
    Total Current Assets899,964,000USD1,326,633,000USD1,085,819,000USD677,616,000USD235,791,000USD184,225,000USD172,911,000USD195,415,000USD
    Total Current Liabilities333,419,000USD240,526,000USD187,350,000USD247,701,000USD90,497,000USD80,504,000USD66,111,000USD52,755,000USD
    Net Debt260,311,000USD-293,376,000USD-96,710,000USD167,856,000USD92,801,000USD156,289,000USD101,480,000USD153,058,000USD
    Short Term Debt738,000USD974,000USD823,000USD354,000USD11,642,000USD20,701,000USD10,286,000USD2,750,000USD
    Short Long Term Debt738,000USD974,000USD823,000USD354,000USD11,642,000USD20,701,000USD10,000,000USD2,750,000USD
    Short Long Term Debt Total619,432,000USD619,438,000USD616,946,000USD583,508,000USD191,309,000USD235,901,000USD194,399,000USD266,459,000USD
    Long Term Debt568,678,000USD565,279,000USD561,670,000USD557,712,000USD163,121,000USD197,699,000USD183,927,000USD263,709,000USD
    Long Term Investments42,213,000USD39,489,000USD0USD—————
    Net Receivables358,640,000USD321,258,000USD284,292,000USD213,397,000USD89,336,000USD54,002,000USD43,529,000USD43,753,000USD
    Inventory64,674,000USD68,025,000USD64,029,000USD35,475,000USD35,129,000USD35,744,000USD29,180,000USD33,019,000USD
    Accounts Payable42,906,000USD34,560,000USD41,189,000USD20,563,000USD20,787,000USD16,284,000USD18,608,000USD17,955,000USD
    Property Plant Equipment Net163,686,000USD212,881,000USD192,022,000USD141,199,000USD125,560,000USD138,612,000USD116,497,000USD107,888,000USD
    Property Plant Equipment Gross267,451,000USD321,643,000USD299,045,000USD241,327,000USD214,475,000USD120,171,000USD116,497,000USD107,888,000USD
    Accumulated Other Comprehensive Income-1,307,000USD-1,615,000USD-1,037,000USD-1,259,000USD-484,999USD-2,048,000USD-960,000USD-1,108,000USD
    Common Stock Shares Outstanding68,443,000shares71,651,000shares70,239,000shares70,671,000shares67,486,000shares54,134,000shares40,113,000shares39,501,000shares
    Non Current Assets Total1,327,435,000USD653,707,000USD565,330,000USD643,642,000USD627,993,000USD685,596,000USD233,008,000USD244,416,000USD
    Non Current Liabilities Total804,183,000USD651,803,000USD647,907,000USD626,410,000USD308,848,000USD275,112,000USD225,207,000USD316,074,000USD
    Non Current Liabilities Other131,105,000USD9,995,000USD8,868,000USD20,713,000USD145,727,000USD77,413,000USD41,280,000USD52,365,000USD
    Non Currrent Assets Other50,044,000USD8,154,000USD9,936,000USD15,322,000USD29,970,000USD42,193,000USD21,627,000USD30,232,000USD
    Net Working Capital566,545,000USD1,086,107,000USD898,469,000USD429,915,000USD145,294,000USD103,721,000USD106,800,000USD142,660,000USD
    Unclassified Non Current Assets109,196,000USD170,233,000USD150,198,000USD-15,322,000USD-38,758,000USD-60,634,000USD-20,692,000USD-30,232,000USD
    Unclassified Non Current Liabilities104,400,000USD76,529,000USD77,369,000USD—-145,727,000USD-77,413,000USD-40,468,000USD-52,365,000USD
    Unclassified Equity410,164,000USD642,263,000USD682,028,000USD715,186,000USD684,794,999USD664,861,000USD251,248,000USD239,480,000USD
    Current Deferred Revenue——130,174,000USD—52,714,000USD41,726,000USD35,262,000USD30,010,000USD
    Unclassified Current Liabilities——-130,997,000USD—-64,356,000USD-62,427,000USD-45,262,000USD-32,760,000USD
    Other Liab———43,256,000USD145,727,000USD77,413,000USD40,468,000USD52,365,000USD
    Other Assets———125,969,000USD101,522,000USD130,781,000USD92,526,000USD111,681,000USD
    Treasury Stock———-75,000,000USD————
    Net Tangible Assets———70,673,000USD54,740,000USD79,561,000USD91,551,000USD46,155,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation33,400,000USD
    Stock Based Compensation36,048,000USD
    Other Non Cash Items3,314,000USD
    Change To Account Receivables1,044,000USD
    Change To Inventory5,414,000USD
    Change To Liabilities23,282,000USD
    Change In Working Capital12,882,000USD
    Operating Cash Flow217,330,000USD
    Other Investing Activities5,000,000USD
    Unclassified Investing Cash Flow18,963,000USD
    Investing Cash Flow23,963,000USD
    Net Debt Issuance-464,000USD
    Common Stock Issuance2,590,000USD
    Net Common Stock Issuance-17,797,000USD
    Unclassified Financing Cash Flow8,553,000USD
    Financing Cash Flow-7,118,000USD
    Effect Of Forex Changes On Cash14,000USD
    Change In Cash234,189,000USD
    End Cash Flow595,015,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income118,417,000USD54,088,000USD27,771,000USD78,755,000USD72,945,000USD-11,790,000USD131,092,999USD62,073,000USD
    Depreciation22,683,000USD22,818,000USD20,408,000USD13,231,000USD13,626,000USD17,285,000USD17,075,000USD14,819,000USD
    Stock Based Compensation16,041,000USD17,543,000USD24,501,000USD22,321,000USD21,198,000USD22,164,000USD20,366,000USD18,479,000USD
    Other Non Cash Items-58,131,000USD31,341,000USD26,877,000USD-8,703,000USD16,107,000USD142,510,000USD-14,957,999USD83,391,000USD
    Change To Account Receivables-2,232,000USD-2,067,000USD12,830,000USD-2,288,000USD-26,363,000USD7,202,000USD43,141,000USD-32,588,000USD
    Change To Inventory2,113,000USD-3,041,000USD-915,000USD-5,688,000USD278,000USD4,431,000USD874,000USD519,000USD
    Change In Working Capital22,831,000USD-16,285,000USD1,282,000USD-10,928,000USD-18,303,000USD33,021,000USD38,625,000USD-56,674,000USD
    Total Cash From Operating Activities125,127,000USD90,178,000USD105,294,000USD87,106,000USD107,563,000USD155,399,000USD175,062,000USD84,720,000USD
    Capital Expenditures-3,226,000USD-8,788,000USD-10,622,000USD-13,374,000USD-8,718,000USD-16,369,000USD-15,808,000USD-11,175,000USD
    Free Cash Flow121,901,000USD81,390,000USD94,672,000USD73,732,000USD98,845,000USD139,030,000USD159,254,000USD73,545,000USD
    Total Cashflows From Investing Activities25,986,000USD-11,510,000USD-319,468,000USD-232,472,000USD-63,718,000USD-6,602,000USD-67,798,000USD-45,086,000USD
    Net Borrowings-216,000USD-353,000USD-292,000USD-63,000USD-402,000USD58,000USD252,000USD—
    Total Cash From Financing Activities-11,623,000USD-100,786,000USD-99,166,000USD-98,413,000USD-18,219,000USD-101,328,000USD1,869,000USD99,000USD
    Issuance Of Capital Stock0USD1,000USD——1,983,000USD0USD1,627,000USD0USD
    Change In Cash139,461,000USD-22,885,000USD-313,566,000USD-242,952,000USD25,728,000USD46,428,000USD109,368,000USD38,739,000USD
    Begin Period Cash Flow359,121,000USD382,006,000USD695,572,000USD940,214,000USD914,486,000USD866,386,000USD757,018,000USD718,279,000USD
    End Period Cash Flow498,582,000USD360,826,000USD382,006,000USD697,262,000USD940,214,000USD912,814,000USD866,386,000USD757,018,000USD
    Other Cashflows From Financing Activities-15,695,000USD-1,098,000USD-759,000USD3,633,000USD-19,800,000USD-892,000USD-1,299,000USD-1,006,000USD
    Unclassified Operating Cash Flow3,286,000USD-19,327,000USD4,455,000USD-7,570,000USD1,990,000USD-47,791,000USD-17,139,000USD-37,368,000USD
    Unclassified Investing Cash Flow29,212,000USD-8,135,000USD325,046,000USD18,787,000USD8,718,000USD-1,398,000USD57,818,000USD45,086,000USD
    Unclassified Financing Cash Flow4,288,000USD—1,885,000USD-1,983,000USD——-17,508,000USD2,111,000USD
    Sale Purchase Of Stock—-100,017,000USD-100,000,000USD-100,000,000USD—-100,000,000USD20,424,000USD-1,006,000USD
    Other Cashflows From Investing Activities—5,413,000USD-314,424,000USD-5,413,000USD—17,767,000USD-42,010,000USD-33,911,000USD
    Investments——-319,468,000USD-232,472,000USD-63,718,000USD-6,602,000USD-67,798,000USD-45,086,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income233,559,000USD312,442,000USD326,661,000USD28,067,000USD-71,279,000USD-13,473,000USD31,667,000USD40,518,000USD
    Depreciation70,098,000USD64,624,000USD60,043,000USD47,929,000USD42,288,000USD24,689,000USD13,379,000USD13,929,000USD
    Stock Based Compensation85,563,000USD76,393,000USD50,507,000USD29,262,000USD15,934,000USD14,075,000USD12,492,000USD8,718,000USD
    Other Non Cash Items109,123,000USD114,036,000USD94,881,000USD302,527,000USD78,481,000USD14,194,000USD6,593,000USD5,874,000USD
    Change To Account Receivables-17,888,000USD-37,685,000USD-68,637,000USD-128,460,000USD-33,102,000USD-7,462,000USD156,000USD-3,985,000USD
    Change To Inventory-9,366,000USD-2,670,000USD-36,220,000USD-7,508,000USD-3,549,000USD-8,459,000USD1,994,000USD-8,690,000USD
    Change In Working Capital-44,234,000USD2,048,000USD-171,200,000USD-75,065,000USD-15,154,000USD-22,365,000USD9,049,000USD-13,972,000USD
    Total Cash From Operating Activities390,141,000USD544,750,000USD305,260,000USD281,781,000USD53,916,000USD16,396,000USD80,384,000USD61,193,000USD
    Capital Expenditures-36,089,000USD-51,625,000USD-46,555,000USD-18,347,000USD-12,140,000USD-12,474,000USD-22,061,000USD-20,132,000USD
    Free Cash Flow354,052,000USD493,125,000USD258,705,000USD263,434,000USD41,776,000USD3,922,000USD58,323,000USD41,061,000USD
    Total Cashflows From Investing Activities-627,168,000USD-226,015,000USD5,939,000USD-276,547,000USD3,683,000USD-4,912,000USD-22,061,000USD-19,132,000USD
    Net Borrowings-1,110,000USD-318,000USD-717,000USD382,270,000USD-43,348,000USD-16,715,000USD-78,173,000USD-2,862,000USD
    Total Cash From Financing Activities-316,584,000USD-118,536,000USD-13,062,000USD311,691,000USD-39,332,000USD-21,861,000USD-78,881,000USD-4,668,000USD
    Sale Purchase Of Stock-300,017,000USD-100,000,000USD-14,394,000USD-75,000,000USD-2,045,999USD-2,129,000USD-2,454,000USD-3,386,000USD
    Issuance Of Capital Stock3,727,000USD3,450,000USD1,933,000USD1,375,000USD767,000USD683,000USD573,000USD428,000USD
    Change In Cash-553,660,000USD199,201,000USD298,044,000USD316,590,000USD17,957,000USD-10,225,000USD-20,482,000USD37,111,000USD
    Begin Period Cash Flow914,486,000USD715,285,000USD417,241,000USD100,651,000USD82,694,000USD92,919,000USD113,401,000USD76,290,000USD
    End Period Cash Flow360,826,000USD914,486,000USD715,285,000USD417,241,000USD100,651,000USD82,694,000USD92,919,000USD113,401,000USD
    Other Cashflows From Investing Activities-591,079,000USD17,767,000USD52,494,000USD-258,200,000USD15,823,000USD-10,000,000USD—1,000,000USD
    Other Cashflows From Financing Activities-26,338,000USD-21,668,000USD-14,278,000USD2,951,000USD3,249,000USD-7,053,000USD-1,281,000USD-2,234,000USD
    Unclassified Operating Cash Flow-63,968,000USD-24,793,000USD-55,632,000USD-50,939,000USD3,646,000USD—7,204,000USD6,126,000USD
    Unclassified Financing Cash Flow10,881,000USD3,450,000USD16,327,000USD—4,858,998USD6,165,000USD5,481,000USD3,814,000USD
    Investments—-226,015,000USD-246,716,000USD-276,547,000USD3,683,000USD-10,000,000USD-22,061,000USD-19,132,000USD
    Unclassified Investing Cash Flow—33,858,000USD246,716,000USD276,547,000USD-3,683,000USD27,562,000USD22,061,000USD19,132,000USD
    Change To Liabilities———51,399,000USD5,425,000USD-5,557,000USD-3,846,000USD2,583,000USD
    Cash And Cash Equivalents Changes———316,925,000USD18,267,000USD-10,377,000USD-20,558,000USD37,111,000USD
    Dividends Paid————-2,045,999USD-2,129,000USD-2,454,000USD—
    Exchange Rate Changes———————-282,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30GeographyInternational19,888,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyUnited States368,292,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyInternational22,908,000USD0001193125-26-210373
    Q1 2026Quarterly · 2026-03-31GeographyUnited States354,425,000USD0001193125-26-210373
    FY 2025Yearly · 2025-12-31GeographyInternational82,728,000USD0001193125-26-073498
    FY 2025Yearly · 2025-12-31GeographyUnited States1,458,881,000USD0001193125-26-073498
    Q1 2025Quarterly · 2025-03-31GeographyInternational15,009,000USD0001193125-26-210373
    Q1 2025Quarterly · 2025-03-31GeographyUnited States357,755,000USD0001193125-26-210373
    FY 2024Yearly · 2024-12-31GeographyInternational49,223,000USD0001193125-26-073498
    FY 2024Yearly · 2024-12-31GeographyUnited States1,484,687,000USD0001193125-26-073498
    FY 2023Yearly · 2023-12-31GeographyInternational34,283,000USD0001193125-26-073498
    FY 2023Yearly · 2023-12-31GeographyUnited States1,262,146,000USD0001193125-26-073498
    Q3 2023Quarterly · 2023-09-30ProductDefinity67,336,000USD0001628280-24-045459
    Q3 2023Quarterly · 2023-09-30ProductLicenseand Royalty Revenues438,000USD0001628280-24-045459
    Q3 2023Quarterly · 2023-09-30ProductOther Precision Diagnostics5,740,000USD0001628280-24-045459
    Q3 2023Quarterly · 2023-09-30ProductOther Radiopharmaceutical Oncology848,000USD0001628280-24-045459
    Q3 2023Quarterly · 2023-09-30ProductRadiopharmaceutical Oncology — PYLARIFY215,428,000USD0001628280-24-045459
    Q3 2023Quarterly · 2023-09-30ProductStrategic Partnerships And Other7,322,000USD0001628280-24-045459
    Q3 2023Quarterly · 2023-09-30ProductTechne Lite23,272,000USD0001628280-24-045459
    FY 2020Yearly · 2020-12-31SegmentInternational44,614,000USD0001628280-21-003336
    FY 2020Yearly · 2020-12-31SegmentUs294,796,000USD0001628280-21-003336
    Q4 2020Quarterly · 2020-12-31SegmentInternational12,975,000USDLegacy provider
    Q4 2020Quarterly · 2020-12-31SegmentUs81,177,000USDLegacy provider
    Q3 2020Quarterly · 2020-09-30ProductDefinity55,429,000USD0001628280-20-015734
    Q3 2020Quarterly · 2020-09-30ProductOther Nuclear17,167,000USD0001628280-20-015734
    Q3 2020Quarterly · 2020-09-30ProductRebates And Allowances-5,541,000USD0001628280-20-015734
    Q3 2020Quarterly · 2020-09-30ProductTechne Lite21,489,000USD0001628280-20-015734
    Q3 2020Quarterly · 2020-09-30SegmentInternational11,069,000USD0001628280-20-015734
    Q3 2020Quarterly · 2020-09-30SegmentUs77,475,000USD0001628280-20-015734
    Q2 2020Quarterly · 2020-06-30SegmentInternational8,611,000USD0001628280-20-011352
    Q2 2020Quarterly · 2020-06-30SegmentUs57,399,000USD0001628280-20-011352
    Q1 2020Quarterly · 2020-03-31ProductDefinity52,505,000USD0001628280-21-008749
    Q1 2020Quarterly · 2020-03-31ProductLicenseand Royalty Revenues491,000USD0001628280-21-008749
    Q1 2020Quarterly · 2020-03-31ProductOther Precision Diagnostics13,057,000USD0001628280-21-008749
    Q1 2020Quarterly · 2020-03-31ProductRadiopharmaceutical Oncology1,968,000USD0001628280-21-008749
    Q1 2020Quarterly · 2020-03-31ProductStrategic Partnerships And Other395,000USD0001628280-21-008749
    Q1 2020Quarterly · 2020-03-31ProductTechne Lite22,779,000USD0001628280-21-008749
    Q1 2020Quarterly · 2020-03-31SegmentInternational11,959,000USD0001628280-20-005914
    Q1 2020Quarterly · 2020-03-31SegmentUs78,745,000USD0001628280-20-005914
    FY 2019Yearly · 2019-12-31SegmentInternational43,348,000USD0001628280-21-003336
    FY 2019Yearly · 2019-12-31SegmentUs303,989,000USD0001628280-21-003336
    Q4 2019Quarterly · 2019-12-31SegmentInternational10,631,000USDLegacy provider
    Q4 2019Quarterly · 2019-12-31SegmentUs78,715,000USDLegacy provider
    FY 2019Yearly · 2019-12-31ProductDefinity217,508,000USD0001628280-21-003336
    FY 2019Yearly · 2019-12-31ProductOther Nuclear59,805,000USD0001628280-21-003336
    FY 2019Yearly · 2019-12-31ProductRebates And Allowances-16,568,000USD0001628280-21-003336
    FY 2019Yearly · 2019-12-31ProductTechne Lite86,592,000USD0001628280-21-003336
    Q3 2019Quarterly · 2019-09-30ProductDefinity52,395,000USD0001628280-20-015734
    Q3 2019Quarterly · 2019-09-30ProductOther Nuclear15,541,000USD0001628280-20-015734
    Q3 2019Quarterly · 2019-09-30ProductRebates And Allowances-3,907,000USD0001628280-20-015734
    Q3 2019Quarterly · 2019-09-30ProductTechne Lite21,747,000USD0001628280-20-015734
    Q3 2019Quarterly · 2019-09-30SegmentInternational11,126,000USD0001628280-20-015734
    Q3 2019Quarterly · 2019-09-30SegmentUs74,650,000USD0001628280-20-015734
    Q2 2019Quarterly · 2019-06-30SegmentInternational10,515,000USD0001628280-20-011352
    Q2 2019Quarterly · 2019-06-30SegmentUs75,190,000USD0001628280-20-011352
    Q1 2019Quarterly · 2019-03-31ProductLicenseand Royalty Revenues527,000USD0001521036-19-000007
    Q1 2019Quarterly · 2019-03-31ProductProduct Revenue Net85,983,000USD0001521036-19-000007
    Q1 2019Quarterly · 2019-03-31SegmentInternational11,076,000USD0001628280-20-005914
    Q1 2019Quarterly · 2019-03-31SegmentUs75,434,000USD0001628280-20-005914
    FY 2018Yearly · 2018-12-31GeographyAll Other54,794,000USD0001628280-19-001574
    FY 2018Yearly · 2018-12-31GeographyUnited States288,580,000USD0001628280-19-001574
    Q4 2018Quarterly · 2018-12-31ProductLicenseand Royalty Revenues531,000USDLegacy provider
    Q4 2018Quarterly · 2018-12-31ProductProduct Revenue Net85,740,000USDLegacy provider
    FY 2018Yearly · 2018-12-31SegmentInternational54,794,000USD0001628280-21-003336
    FY 2018Yearly · 2018-12-31SegmentUs288,580,000USD0001628280-21-003336
    FY 2018Yearly · 2018-12-31ProductDefinity183,073,000USD0001628280-21-003336
    FY 2018Yearly · 2018-12-31ProductOther Nuclear74,284,000USD0001628280-21-003336
    FY 2018Yearly · 2018-12-31ProductRebates And Allowances-12,841,000USD0001628280-21-003336
    FY 2018Yearly · 2018-12-31ProductTechne Lite98,858,000USD0001628280-21-003336
    Q3 2018Quarterly · 2018-09-30ProductLicenseand Royalty Revenues576,000USD0001628280-18-013111
    Q3 2018Quarterly · 2018-09-30ProductProduct Revenue Net88,324,000USD0001628280-18-013111
    Q2 2018Quarterly · 2018-06-30ProductLicenseand Royalty Revenues569,000USD0001628280-18-010222
    Q2 2018Quarterly · 2018-06-30ProductProduct Revenue Net85,004,000USD0001628280-18-010222
    FY 2017Yearly · 2017-12-31GeographyAll Other22,606,000USD0001628280-18-002261
    FY 2017Yearly · 2017-12-31GeographyCanada18,770,000USD0001628280-18-002261
    FY 2017Yearly · 2017-12-31GeographyUnited States290,002,000USD0001628280-18-002261
    FY 2017Yearly · 2017-12-31SegmentWorldwide — International41,376,000USD0001628280-20-002197
    FY 2017Yearly · 2017-12-31SegmentWorldwide — Us290,002,000USD0001628280-20-002197
    FY 2017Yearly · 2017-12-31ProductDefinity157,268,000USD0001628280-18-002261
    FY 2017Yearly · 2017-12-31ProductOther Products38,089,000USD0001628280-18-002261
    FY 2017Yearly · 2017-12-31ProductTechne Lite104,644,000USD0001628280-18-002261
    FY 2017Yearly · 2017-12-31ProductXenon31,377,000USD0001628280-18-002261
    FY 2016Yearly · 2016-12-31GeographyAll Other25,515,000USD0001628280-18-002261
    FY 2016Yearly · 2016-12-31GeographyCanada18,918,000USD0001628280-18-002261
    FY 2016Yearly · 2016-12-31GeographyUnited States257,420,000USD0001628280-18-002261
    FY 2016Yearly · 2016-12-31SegmentInternational44,433,000USD0001628280-19-001574
    FY 2016Yearly · 2016-12-31SegmentUs257,420,000USD0001628280-19-001574
    FY 2016Yearly · 2016-12-31ProductDefinity131,612,000USD0001628280-18-002261
    FY 2016Yearly · 2016-12-31ProductOther Products41,938,000USD0001628280-18-002261
    FY 2016Yearly · 2016-12-31ProductTechne Lite99,217,000USD0001628280-18-002261
    FY 2016Yearly · 2016-12-31ProductXenon29,086,000USD0001628280-18-002261
    FY 2015Yearly · 2015-12-31GeographyAll Other29,297,000USD0001628280-18-002261
    FY 2015Yearly · 2015-12-31GeographyCanada28,340,000USD0001628280-18-002261
    FY 2015Yearly · 2015-12-31GeographyUnited States235,824,000USD0001628280-18-002261
    FY 2015Yearly · 2015-12-31SegmentInternational57,637,000USD0001628280-18-002261
    FY 2015Yearly · 2015-12-31SegmentUs235,824,000USD0001628280-18-002261
    FY 2015Yearly · 2015-12-31ProductDefinity111,859,000USD0001628280-18-002261
    FY 2015Yearly · 2015-12-31ProductOther Products60,142,000USD0001628280-18-002261
    FY 2015Yearly · 2015-12-31ProductTechne Lite72,562,000USD0001628280-18-002261
    FY 2015Yearly · 2015-12-31ProductXenon48,898,000USD0001628280-18-002261

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.